What is the latest INFINIUM stock price?
The latest stored price for INFINIUM is Rs 265.00 as of 2026-09-18.
gimli
INFINIUM stock AI analysis
INFINIUM Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
INFINIUM PHARMACHEM LTD is a small-cap stock in Unclassified. This Gimli page shows the latest available INFINIUM price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹265.00
1W return
-3.28%
1M return
+9.01%
3M return
+28.27%
6M return
+30.54%
1Y return
+6.02%
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
+9.23%
ROCE
+11.99%
RSI
54.56
Turnover
₹0.08 cr
Why it can matter in screens
- Momentum: INFINIUM is above 50DMA, above 200DMA; RSI is 54.56.
- Returns: 1D -4.85%, 1W -3.28%, 1M +9.01%, 3M +28.27%, 1Y +6.02%.
- Trend levels: 52W high ₹285.50, 52W low ₹189.40, off high -7.18%.
- Liquidity: latest turnover is ₹0.08 cr; volume vs 20D is +0.27%.
- Valuation/profitability: PE n/a, PB n/a, ROE +9.23%, ROCE +11.99%.
- Growth: 3Y sales CAGR +18.41%, 3Y profit CAGR +8.58%.
Quick Answers
Is INFINIUM above its 50DMA and 200DMA?
INFINIUM is above 50DMA, above 200DMA. The latest 50DMA is 234.01 and the latest 200DMA is 220.44.
What are INFINIUM PE, ROE and ROCE?
INFINIUM has PE n/a, ROE +9.23%, and ROCE +11.99% in Gimli's latest available snapshot.
How has INFINIUM performed recently?
INFINIUM has returned +9.01% over 1 month, +28.27% over 3 months, and +6.02% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 104.58 cr | 12.26 cr | 6.55 cr | 4.20 |
| 2025-03-31 | 72.73 cr | 8.98 cr | 3.74 cr | 2.57 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 189.63 cr | 23.70 cr | 12.15 cr | nan |
| 2025-03-31 | 155.71 cr | 18.54 cr | 8.15 cr | 5.60 |
| 2024-03-31 | 135.66 cr | 19.77 cr | 11.30 cr | 10.61 |
| 2023-03-31 | 114.22 cr | 17.09 cr | 9.49 cr | 6.82 |
| 2022-03-31 | n/a | n/a | n/a | 4.39 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 174.94 cr | 3.00 cr | n/a | 138.46 cr |
| 2025-03-31 | 198.39 cr | 12.03 cr | 47.32 cr | 124.80 cr |
| 2024-03-31 | 85.45 cr | 3.83 cr | 4.00 cr | 60.23 cr |
| 2023-03-31 | 70.61 cr | 5.98 cr | 19.69 cr | 23.78 cr |
| 2022-03-31 | n/a | n/a | 12.14 cr | n/a |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 33.73 cr | 24.05 cr | n/a |
| 2025-03-31 | -29.12 cr | -37.77 cr | n/a |
| 2024-03-31 | 4.92 cr | 1.41 cr | n/a |
| 2023-03-31 | 8.59 cr | 1.12 cr | n/a |
| 2022-03-31 | n/a | n/a | n/a |
Shareholding Trend
No recent data available.
Industry Peers
No recent data available.
Try these prompts
- Analyze INFINIUM PHARMACHEM with valuation, momentum and industry peers
- Compare INFINIUM with other Unclassified stocks
- Show small-cap stocks in Unclassified above 50DMA with positive 1M return
- Find Unclassified stocks with improving momentum and reasonable valuation
Related screen ideas
- View Unclassified stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare INFINIUM with other Unclassified stocks
Data snapshot: 2026-09-18. Not investment advice.